The Global Oncology Molecular Imaging Product Leader will define and execute the global strategy for the oncology molecular imaging portfolio,. This role requires a strong leader with deep scientific expertise and strong business acumen to drive product and market development , and commercial success, prioritizing the U.S. market. The leader will collaborate across R&D, Medical Affairs, Regulatory, Market Access, and commercial teams to deliver innovative solutions that advance PET pipeline across different cancer types and improve patient outcomes worldwide.Job Description
Key Responsibilities
Strategic Leadership
- Develop and implement global product strategy for oncology tracers, leveraging expertise in oncology molecular imaging
- Develop target product profile aligned with voice of customer and addressing unmet medical needs to maximize impact and utility of key assets in the pipeline and inform development strategy
- Build an indication strategy for platform assets that maximizes value creation and help with development priorities that is grounded in business cases and strength of the unmet needs of pan-cancer and beyond cancer assets.
- Lead the Integrated Evidence Generation Plan (IEGP), prioritizing initiatives that accelerate adoption and demonstrate clinical and economic value.
- Drive cross-functional execution of IEGP with Medical Affairs, Marketing, and R&D teams.
Lifecycle Management
- Oversee pre-launch, launch, and post-launch activities across major markets.
- Identify opportunities for label expansion and new indications using real-world evidence and voice of customer insights.
Market Insights
- Analyze global market trends, competitive landscape, and unmet clinical needs to inform strategic decisions.
- Build business cases for geographic expansion beyond the U.S., including clinical development plans and pre-launch strategies.
Cross-Functional Collaboration
- Partner with Clinical Development to align trial endpoints with commercial objectives.
- Establish collaborations with healthcare systems to integrate PET into oncology care pathways.
Stakeholder Engagement
- Build strong relationships with KOLs in oncology and nuclear medicine, leveraging established networks within relevant societies.
Ideal Profile
- Academic degree (PhD, MD, PharmD, APP) in Life Sciences or Engineering (or equivalent advanced degrees), combining scientific depth with strategic business leadership.
- Proven expertise in oncologic imaging and molecular diagnostics, with deep knowledge of Oncology PET imaging
- Established relationships with KOLs and academic leaders in the oncology PET space, enabling strategic partnerships and market influence.
- Demonstrated leadership in global, cross-functional environments, with a track record of driving business growth and innovation.
- Ability to influence diverse cultures and geographies, fostering collaboration and alignment in matrix organization
- Experience in launching diagnostics in US, preferably in the cancer space.
GE HealthCare offers a great work environment, professional development, challenging careers, and competitive compensation. GE HealthCare is an Equal Opportunity Employer. Employment decisions are made without regard to race, color, religion, national or ethnic origin, sex, sexual orientation, gender identity or expression, age, disability, protected veteran status or other characteristics protected by law.
GE HealthCare will only employ those who are legally authorized to work in the United States for this opening. Any offer of employment is conditioned upon the successful completion of a drug screen (as applicable).
While GE HealthCare does not currently require U.S. employees to be vaccinated against COVID-19, some GE HealthCare customers have vaccination mandates that may apply to certain GE HealthCare employees.
Relocation Assistance Provided: No
Top Skills
Similar Jobs
What you need to know about the Austin Tech Scene
Key Facts About Austin Tech
- Number of Tech Workers: 180,500; 13.7% of overall workforce (2024 CompTIA survey)
- Major Tech Employers: Dell, IBM, AMD, Apple, Alphabet
- Key Industries: Artificial intelligence, hardware, cloud computing, software, healthtech
- Funding Landscape: $4.5 billion in VC funding in 2024 (Pitchbook)
- Notable Investors: Live Oak Ventures, Austin Ventures, Hinge Capital, Gigafund, KdT Ventures, Next Coast Ventures, Silverton Partners
- Research Centers and Universities: University of Texas, Southwestern University, Texas State University, Center for Complex Quantum Systems, Oden Institute for Computational Engineering and Sciences, Texas Advanced Computing Center



